During the past decade, California Research Institute conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Research Institute" #1 sponsor was "BioAtla, Inc." with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Loxo Oncology, Inc." with 2 trials sponsored, "Veru Inc." with 2 trials sponsored and "BioNTech SE" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Research Institute" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "DSCS CRO" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "California Research Institute" are "Chronic Lymphocytic Leukemia" (2 trials), "Metastatic Breast Cancer" (2 trials), "Myelofibrosis" (2 trials), "Non Small Cell Lung Cancer" (2 trials) and "Post Essential Thrombocythemia Myelofibrosis" (2 trials). Many other conditions were trialed in "California Research Institute" in a lesser frequency.

Most popular intervention types in "California Research Institute" are "Drug" (11 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (2 trials), "PD-1 inhibitor" (2 trials), "Rituximab" (2 trials), "parsaclisib" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "California Research Institute" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "California Research Institute". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in California Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in California Research Institute, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".